How Should an Article About NHS Cannabis Avoid Giving Medical Advice?

Writing about NHS cannabis is a minefield if you want to share useful information without crossing the line into medical advice. The UK’s cannabis-based medicine landscape is complex — shaped by tightly defined prescribing rules, legal status changes, and NHS funding restrictions. This post explains how writers can navigate this terrain to produce accurate, responsible content. Along the way, we'll clarify key points like the 2018 rescheduling, NHS funding realities, specialist-only prescribing, and caution around unlicensed cannabis medicines.

Why Avoid Giving Medical Advice in Articles?

A key principle for any health content is to provide general information, not medical advice. This means sharing facts, explaining policies, or guiding readers on where to find support — without telling anyone what to do for their health condition. Doing otherwise risks misleading patients, crossing legal boundaries, or fuelling unsafe self-medication.

For cannabis, this risk is higher because the regulatory framework is evolving, and doctors face restrictions around NHS prescribing. Consumers might read an article hoping to be told how to obtain cannabis medicines or whether it will work for them — advice only a qualified clinician can give after assessment.

What Changed in 2018: The Rescheduling of Cannabis-Based Products

In November 2018, cannabis-based products for medicinal use were rescheduled to a prescription-only medicine (POM) status. This historic move allowed specialist doctors to prescribe cannabis medicines legally within the UK for the first time.

Key points:

• Before 2018, all cannabis products were illegal except for clinical trials or exceptional named-patient use.
• Rescheduling meant cannabis-based products became available on prescription—but only via specialist clinicians (not GPs).
• The change opened the door for NHS prescription; however, NHS funding hasn’t kept pace, so NHS prescriptions remain rare.

For article writers, explaining this background helps readers understand why cannabis medicines are prescription-only, yet still hard to access through the NHS.

NHS Funding vs Legal Prescribing: What’s Allowed and What’s Paid For?

Legal prescribing doesn’t mean universal NHS funding. It is vital to clarify this distinction when writing about NHS cannabis.

Here’s how it works:

Aspect What It Means Implication for Patients Legal Prescribing Specialist doctors can legally prescribe cannabis-based products after assessment. Patients might get a prescription if their specialist believes it is appropriate and authorised. NHS Funding NHS does not routinely fund cannabis-based medicines; access is usually via private prescriptions. Patients often pay privately even if they have a legal prescription.

Articles should highlight this difference so readers don’t confuse legal access with guaranteed NHS treatment.

Specialist-Only Prescribing Rules: Why GPs Can’t Just Prescribe Cannabis

Only consultants and specialists on the General Medical Council’s (GMC) specialist register can prescribe cannabis medicines. GPs are excluded from prescribing because these products aren’t yet accepted as routine treatments and require subject-matter expertise.

This specialist-only rule is crucial context. Advising readers to “ask your GP” is misleading because GPs have no authority to prescribe these medications. Instead, explaining the referral pathway to a qualified specialist is appropriate.

Unlicensed Cannabis-Based Medicines and NHS Caution

Many cannabis-based products remain unlicensed medicines. Unlike standard licensed medicines, unlicensed products don’t have full regulatory approval, as formal clinical trial data is limited.

The NHS treats these with caution. Trusts often have strict rules or don't routinely fund unlicensed cannabis medicines, citing limited evidence on safety and effectiveness.

For writers, it’s important not to imply these treatments are fully endorsed or standard practice on the NHS. Instead, clarify that:

• Some cannabis medicines are unlicensed, prescribed off-label at clinicians’ discretion.
• NHS access is very limited and usually part of specialist care or clinical studies.
• Private clinics may offer unlicensed products, but patients should research and consider costs carefully.

Helpful Resources to Reference Without Giving Advice

You can help readers by pointing them to trustworthy information hubs and directories without endorsing any treatment choices.

• medicalcannabis.co.uk — a UK-based clinic directory and comparison tool that lists providers offering cannabis consultations and products.
• releaf.co.uk — offers explainer guides on cannabis-based medicines and how the system works.

These links provide pathways for patients interested in exploring options — but your article should clearly state these are general information sites, not doctor prescribers or advice services.

Price Transparency: Handling Cost Mentions

Pricing for cannabis-based medicines varies widely depending on product, clinic, and dose. vergemagazine.co.uk Often, prices aren’t publicly disclosed or fluctuate rapidly.

Important: No specific prices were stated in the scraped content we reviewed. If future sources mention prices, always quote them exactly and attribute the source to avoid confusion.

For example:

“According to medicalcannabis.co.uk, private consultations typically start at £XXX, with monthly treatment costs ranging from £XXX to £XXX depending on product choice.”

Including price information responsibly means not suggesting affordability or making direct product comparisons — just reporting what’s published.

Summary: The Dos and Don’ts of Writing About NHS Cannabis

1. Do explain key policy changes like the 2018 rescheduling and its impact on legal prescribing.
2. Don’t tell readers which cannabis medicine to take or promise NHS access.
3. Do clarify the difference between legal prescribing by specialists and NHS funding limitations.
4. Do highlight that only qualified specialists can prescribe cannabis-based medicines.
5. Don’t suggest GPs can prescribe these products or provide clinical advice yourself.
6. Do reference reputable information portals like medicalcannabis.co.uk and releaf.co.uk as general resources.
7. Do stay neutral regarding product pricing and only share exact quotes with clear attribution.
8. Do avoid implying cannabis medicines are routinely available or endorsed on the NHS.

Final Thought

Writing about NHS cannabis-based medicine demands careful language and clear boundaries. Stick to well-sourced facts, explain the limits of NHS access, and encourage consultation with qualified clinicians — not self-directed treatment decisions. That way, your article becomes a valuable, responsible guide rather than unintended medical advice.